Buy
Sell
Share Name Share Symbol Market Type Share ISIN Share Description
Futura Medical Plc LSE:FUM London Ordinary Share GB0033278473 ORD 0.2P
  Price Change % Change Share Price Bid Price Offer Price High Price Low Price Open Price Shares Traded Last Trade
  11.00 25.0% 55.00 55.00 57.00 56.80 43.00 45.90 3,100,912 16:35:26
Industry Sector Turnover (m) Profit (m) EPS - Basic PE Ratio Market Cap (m)
Pharmaceuticals & Biotechnology 0.0 -2.9 -1.0 - 141

Futura Medical Share Discussion Threads

Showing 20576 to 20595 of 21475 messages
Chat Pages: Latest  835  834  833  832  831  830  829  828  827  826  825  824  Older
DateSubjectAuthorDiscuss
24/3/2021
10:28
Also don’t forget when formal EU approval is granted, and should Futura Medical’s share price exceed 30p for a month, the £1.5m in convertible loan notes will mandatorily convert into equity at 20p. Seen it before with these types of convertible loan transactions on AIM where the loan in theory after a share price rise has now significantly increased in paper value. So what do some of the Special purpose vehicles do to the shares after the share price has risen? Many try to realise some of that underlying equity value upside and hedge that capital outlay on the loan by short selling the shares back down to the convertible price. Its a free bet for them. Futura will also issue warrants to Riverwood which confer rights to purchase a total of 2,272,727 ordinary Shares in Futura with 4-year expiration from the date of issue and an exercise price of £0.22 per warrant. This would result in £0.5 million financing for Futura. Full exercise of the loan notes and warrants would result in issuance of 9,772,727 new ordinary shares to Riverwood. And don’t forget Lombard Odier. The put in over £2mln acquiring shares at 8p in December 2019 and also received 9.4mln warrants vesting at 40p. We have seen it before when Lombard Odier tried to sell shares how massive stock overhangs caused Futura and other AIM shares to collapse. Some will also remember how a few years back they even sold shares after the Futura share price had one of its previous spikes and then bought them and more back in a discounted share placing. I will try find the old threads when we discussed it on here.
lbo
24/3/2021
10:26
andyr42 If you listen to the final couple of minutes of the latest Ken James head of R&D Futura (ex Glaxo) on proactive,it is quite clear the phone has been ringing off the hook. All this recent press coverage will have been remarkable and will spur potential co's into action for FOMO. News is imminent covering deals across much of the globe.
j777j
24/3/2021
10:10
J777J I am with you on that. The CE mark carries a big potential value. It's done and next challenge is strategic partnerships with upfront payments. The marketing of this product is already in the public domain and guess what it's free. The product literally markets itself. Next the commercials which could be humongous just on CE. If people don't like it then move on. But I guess they have their ulterior motives but that will be short lived. SP is nicely consolidating at these levels, the next RNS it could BOOM. GLA.
andyr42
24/3/2021
10:07
The Chinese committed up to £6 million. Do you really think didn't do due diligence? Money talks BS walks
j777j
24/3/2021
10:02
LBO. Did you sell on the spike and then open a short?
chickndinner
24/3/2021
09:52
The next RNS is likely to see the share price spike well over 100p The co has EU approval for a medical device and the next news will include issuance of CE mark,a formality,along with deals,deal ,deals. These may well include significant upfront payments. Extension of patent will bring it to 2040 and we should hear about that pretty soon too.It was applied for in dec 2019 If people don't understand the difference in where the co is today,pity them. Many on this board have come on to tell us all to sell for years now. I simply bought and added. LBO has clearly got mental issues he needs to address.If he doesn't like the co he can go find another. Simples. The doing us all a favour spiel is simply BS I think I will follow the Chinese investors instead.After all they put their money where their mouth was.
j777j
24/3/2021
09:50
So have you been trading it or a mixture of trading pot and investment? With your knowledge do you think this is still a good entry level or just a hold for you?
billthebank
24/3/2021
09:33
Bill seen all the prices come and go over the years.From IPO in 2003 at 70p and all the way down to 15p in 2008 after and then all the way back up over £1 in 2012https://www.bloomberg.com/news/articles/2011-12-07/-viagra-in-a-condom-may-make-u-k-s-futura-a-target-of-reckitt-benckiserhttps://www.thisismoney.co.uk/money/markets/article-2124605/MARKET-REPORT-Futura-soars-takeover-talk.htmlAnd then all the way back down to the 8p fundraising in December 2019 and then back up to the 60p level today.
lbo
24/3/2021
09:31
Why the hostility to LBO? I'm new to the stock and have found his posts very useful in understanding the history of the company and its previous product portfolio. Did management ever explain why CSD500 and PET500 failed to gain traction in the market? When was this and what eventually happened to these products? LBO highlights that having a strong go to market strategy is as important as having a good product. Another important issue is the patent expiration. Liberum's report in May 2020 has sales peaking in 2028. That doesn't give much time for MED3000 to generate the necessary free cashflow to support the valuation. Management has talked about this being extended by around ten years which is important to the valuation and in finding the right commercial partners. Does anyone know whether extending the patent protection around MED3000 is a strong possibility?
boros10
24/3/2021
09:29
They need to rub some of their cream on the share price again.
regandharry5
24/3/2021
09:26
Or do you have another reason for watching?!!!!!
billthebank
24/3/2021
09:16
Whst price did you get in at? And what price do you hope to get out at?
billthebank
24/3/2021
09:13
Been posting on FUM on advfn for many many years. Seen all the products like PET500 and CSD500 with two of the largest condom brands in the world Durex and Trojan sadly come and go. Like many had high hopes for MED2005 too at one stage and always wondered why Glaxo walked away from it and Reckitt never wanted it either. Also doubt MED3000 will ever actually generate anything near the sales some day traders are throwing around but maybe it has some potential to be sold off. The FDA study and some simple consumer comparison studies will answer those questions. Also still waiting on an update on TPR100 and the Thornton Ross deal in the Uk.
lbo
24/3/2021
08:55
LBO. So why are you here. Answers on a post card please
firedriver
24/3/2021
08:41
Glavey some simple comparison studies is all that is needed with Dermasys and presumably will be required by distribution and licensing partners before any real deals are ever signed.https://www.metrotimes.com/detroit/3-male-enhancement-creams-gels-that-work-instantly-and-safely-get-proofs/Content?oid=26569960
lbo
24/3/2021
08:36
So Leewain and Johnny Butler disappear and LBO is now the resident deramper.....one guess who LBO is?
tiananmen
24/3/2021
08:31
Yes it is going to shoot up
bag158s
24/3/2021
08:28
Some big buys right there, someone's very interested
northster2
24/3/2021
08:22
Firedriver many Futura shareholders have seen and heard all this hype before. The day traders and speculators always come along once and a while to hype it up, then sell out and move on. The only other one constant so far has been the lack of revenue from Royalties.http://www.directorstalk.net/wp-content/uploads/2015/03/FUM-FY14-results-update-26-Mar-2015.pdfhttp://www.directorstalkinterviews.com/wp-content/uploads/2015/09/FUM-Interim-results-9-Sept-2015_0.pdf
lbo
24/3/2021
08:21
Shorts getting toasted.
albert arthur
Chat Pages: Latest  835  834  833  832  831  830  829  828  827  826  825  824  Older
ADVFN Advertorial
Your Recent History
LSE
FUM
Futura Med..
Register now to watch these stocks streaming on the ADVFN Monitor.

Monitor lets you view up to 110 of your favourite stocks at once and is completely free to use.

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

P: V: D:20210512 18:27:37